Among people who die from diseases in the world, deaths caused by atherosclerotic cardiovascular disease rank at the forefront. One of the important pathogenic risk factors in the development of atherosclerotic cardiovascular disease is dyslipidemia. Therefore, lipid-lowering drugs play an important role in preventing and controlling atherosclerotic cardiovascular disease.What...
Friday, October 13, 2023
The latest article ヽ( ・◇・)ノ
An introduction to pembrolizumab (Keytruda®) and its common usage and dosage.👀👀👀
Pembrolizumab is a monoclonal antibody. It is a programmed death receptor-1 (PD-1) blocker. The PD-1 receptor expressed by T cells binds to ...